ELRIG Announces Drug Discovery 2012 Keynotes and Workshops
Published: Aug 14, 2012
Keynote presentations will be given by Dr Steve Rees, Vice-President of Screening Sciences and Sample Management at AstraZeneca, and Section President of SLAS (‘Collaborative Models for Lead Discovery’), and Dr Chris Moxham, Associate Vice President at ImClone Systems, a wholly owned subsidiary of Eli Lilly and Company (‘Eli Lilly and Co.'s Open Innovation Drug Discovery Initiative’). The keynote speakers will also close the meeting with a debate on ‘The Evolving Landscape for Drug Discovery’.
A number of vendor workshop sessions will be held during the event, as well as lunchtime ‘Informatics: Making Knowledge from Laboratory Data’ Seminars on both days of the event. The lunchtime Informatics Seminars are: ‘How best to enable externalisation of drug discovery’ and ‘Knowledge at your finger tips’.
Workshop sessions include: ‘Deeper insights – better prediction of drug safety and efficacy’ from GE Healthcare Drug Discovery Suite; and ‘Early drug de-risking with 3D-cell-culture systems’ with InSphero.
Drug Discovery 2012 is to be held on 5th – 6th September 2012 at the Manchester Central Convention Complex, and features over 100 exhibitor booths, an Innovation Zone, Media Area, Careers Zone and Dragons Den. Registration for the event is free and over 1,000 delegates are expected to attend.
To find out more and to register for the conference please visit www.ELRIG.org
ELRIG is a rapidly growing not-for-profit special interest group focused on the use of robotics and associated technologies in the laboratory and also on the wider applications of laboratory automation.
Membership consists of scientists, researchers, developers, engineers and business-people who are interested in robotics, automation and associated technological developments plus users and vendors of equipment and accessories in this field. ELRIG’s primary objective is to provide an open communication forum for users and vendors, within which members can be educated, share information and experience and network with other members.
Tel: +44 (0)7787 502 947